2020-12-16,Is MDGL A Good Stock To Buy Now?
2020-11-24,Here's Why We're Not Too Worried About Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Situation
2020-11-13,"Madrigal Pharmaceuticals Highlights Presentations at The Liver Meeting Digital Experience, The American Association for the Study of Liver Diseases Meeting November 13, 2020, Including NASH Expert Insights on the Ongoing Open Label Arm of Resmetirom 52-Week Phase 3 MAESTRO-NAFLD-1 Trial"
2020-11-05,Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights
2020-09-03,Madrigal Pharmaceuticals Exceeds Target Enrollment  in Phase 3 MAESTRO NAFLD-1 Trial
2020-09-02,Intercept Pharmaceuticals Will Lay Off a Quarter of Its Staff as NASH Dream Fades
2020-08-26,Madrigal Pharmaceuticals to Present Secondary Analyses of Data from Phase 2 NASH Study of Resmetirom and Symposium at the Digital International Liver Congress 2020
2020-08-06,Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
2020-06-27,"Should You Avoid Madrigal Pharmaceuticals, Inc. (MDGL)?"
2020-06-17,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGL"
2020-06-15,Many 'Ifs' Surrounding Viking Therapeutics
2020-06-15,"Madrigal Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating"
2020-06-06,3 Top Biotech Stocks to Buy in June
2020-05-28,We Think Madrigal Pharmaceuticals (NASDAQ:MDGL) Can Afford To Drive Business Growth
2020-05-14,"After Drug Failure, Genfit's Cupboard Is Nearly Bare"
2020-05-10,Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)?
2020-05-07,Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights
2020-05-05,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGL"
2020-04-14,Madrigal MAESTRO Phase 3 NASH Trials Continue without Protocol Modifications; New Data Demonstrate that Reductions in Liver Fat Achieved by Resmetirom Predict NASH Resolution and Fibrosis Reduction
2020-03-30,FDA Decisions on 5 Drugs Expected in 2nd Quarter
2020-02-28,"What Kind Of Share Price Volatility Should You Expect For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)?"
2020-02-26,Madrigal Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights
2020-02-05,13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market
2020-01-21,Is It Time to Buy These 3 Beaten-Down Stocks? Analysts Say Yes
2019-12-19,"Madrigal Pharmaceuticals, Inc. (MDGL): Hedge Fund Sentiment Unchanged"
2019-12-18,"Madrigal Pharmaceuticals Announces First Patient Dosed in MAESTRO-NAFLD-1, a Second Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Resmetirom (MGL-3196) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Presumed NASH (NASH/NAFLD (non-alcoholic fatty liver disease))"
2019-12-13,Madrigal Pharmaceuticals investor selling large chunk of its stake
2019-12-10,Madrigal Pharmaceuticals Announces Pricing of Secondary Offering
2019-12-10,"Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock"
2019-11-29,NASH Scorecard Year to Date: The Winners and the Losers
2019-11-11,Madrigal Pharmaceuticals Announces Publication in The Lancet of Positive Phase 2 Results for Resmetirom (MGL-3196) for the Treatment of Non-alcoholic Steatohepatitis (NASH)
2019-11-06,Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights
2019-10-26,"Hedge Funds Are Dumping Madrigal Pharmaceuticals, Inc. (MDGL)"
2019-09-19,"What Kind Of Share Price Volatility Should You Expect For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)?"
2019-08-07,Madrigal Pharmaceuticals Reports 2019 Second Quarter Financial Results and Highlights
2019-07-11,"Madrigal Pharmaceuticals Promotes Rebecca Taub, M.D., Chief Medical Officer and Executive Vice President of Research & Development, to Newly Created Position of President of Research & Development"
2019-07-10,"Have Insiders Been Buying Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares?"
2019-07-02,Madrigal Pharmaceuticals Announces Appointment of Jim Daly to Board of Directors
2019-06-19,"Heres What Hedge Funds Think About Madrigal Pharmaceuticals, Inc. (MDGL)"
2019-06-07,2 Falling Knives With No Debt
2019-06-04,Madrigal Pharmaceuticals to Present at Upcoming Investment Conferences
2019-05-15,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Certain Officers and Directors of Madrigal Pharmaceuticals, Inc."
2019-05-08,"If You Had Bought Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock A Year Ago, You'd Be Sitting On A 12% Loss, Today"
2019-05-08,Madrigal: 1Q Earnings Snapshot
2019-05-08,Madrigal Pharmaceuticals Reports 2019 First Quarter Financial Results and Highlights
2019-05-01,"Is Madrigal Pharmaceuticals, Inc. (MDGL) A Good Stock To Buy?"
2019-04-08,Madrigal Pharmaceuticals to Present Additional Analyses of Data from The Phase 2 NASH Study with MGL-3196 (resmetirom) at The International Liver Congress 2019
2019-04-06,Here's Why Investors Are Betting Against These 2 Biotech Stocks
2019-03-28,"Madrigal Pharmaceuticals Initiates Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation"
2019-03-01,"Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus"
2019-02-27,Is Viking Therapeutics a Buy?
2019-02-27,"All You Need To Know About Madrigal Pharmaceuticals, Inc.s (NASDAQ:MDGL) Financial Health"
2019-02-27,Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights
2019-02-20,"Intercept Reports Positive Top-Line Data for NASH, Shares Up"
2019-02-17,Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals
2019-02-12,Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails
2019-01-11,Here's Why Viking Therapeutics Slid 32.2% in December
2019-01-08,Here's Why Viking Therapeutics Skyrocketed 88.4% in 2018
2018-12-28,Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018
2018-12-12,"Here is What Hedge Funds Think About Madrigal Pharmaceuticals, Inc. (MDGL)"
2018-12-12,3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
2018-12-08,Here's Why Madrigal Pharmaceuticals Fell 39.4% in November
2018-11-28,"Report: Exploring Fundamental Drivers Behind CASI Pharmaceuticals, Booking, Enstar Group, Madrigal Pharmaceuticals, Dermira, and Kaiser Aluminum  New Horizons, Emerging Trends, and Upcoming Developments"
2018-11-23,"Madrigal Pharmaceuticals Inc (MDGL) CEO Paul A Friedman Bought $471,520 of Shares"
2018-11-19,"Madrigal Pharmaceuticals Inc (MDGL) CEO Paul A Friedman Bought $496,000 of Shares"
2018-11-19,"Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade"
2018-11-14,"Better NASH Stock: Madrigal Pharmaceuticals, Inc. vs. Viking Therapeutics, Inc."
2018-11-12,Madrigal preparing for late-stage testing of experimental NASH treatment
2018-11-12,Phase 2 Results for Madrigals MGL-3196 in Non-Alcoholic Steatohepatitis (NASH) Presented during Presidential Plenary Clinical Session of The Liver Meeting® 2018
2018-11-12,Why Madrigal Pharmaceuticals Stock Slumped in October
2018-11-06,Madrigal Pharmaceuticals Reports 2018 Third Quarter Financial Results and Highlights Upcoming Clinical Events
2018-10-27,Better Buy: Intercept Pharmaceuticals Inc. vs. Madrigal Pharmaceuticals
2018-10-19,"Research Report Identifies Brookfield Asset Management, Becton, Dickinson, IPG Photonics, ASML Holding N.V, American National Insurance, and Madrigal Pharmaceuticals with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement"
2018-09-26,5 Biotech Stocks to Play the Sectors Next Big Trend: NASH
2018-09-20,Is Viking Therapeutics the Best NASH Stock to Buy Now?
2018-09-19,Today's Research Reports on Trending Tickers: Madrigal Pharmaceuticals and Cara Therapeutics
2018-09-18,Viking Therapeutics and Madrigal Pharmaceuticals Are Racing to the Finish Line in NASH
2018-09-18,Why Viking Therapeutics Stock Is Soaring Today
2018-09-18,UPDATE: Viking Therapeutics stock rockets 140% after positive trial of non-alcoholic fatty liver treatment
2018-09-12,3 Top Stocks for Investing in Pharma's Next $35 Billion Market
2018-08-19,"Is Viking Therapeutics, Inc. a Buy?"
2018-08-07,Madrigal (MDGL) Posts Narrower than Expected Loss in Q2
2018-08-07,Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements
2018-08-06,Goldman Sachs Cuts Madrigal Pharma To Neutral Given No Near-Term Catalysts
2018-07-30,Why Madrigal Pharmaceuticals Stock Is Getting Hammered Today
2018-07-26,How a little 10-employee pharma company hit a whopping $4.4B market cap
2018-07-17,Breakfast Technical Briefing on Mirati Therapeutics and Three Other Additional Biotech Stocks
2018-07-14,The 4 Best Biotech Stocks of 2018 (So Far)
2018-07-11,3 Huge Biotech Winners in 2018 (So Far)
2018-07-03,Today's Research Reports on Trending Tickers: Madrigal Pharmaceuticals and Zuora
2018-07-02,Best ETFs for 2018: ALPS Medical Breakthroughs ETF Keeps Rolling Along
2018-06-26,"Viking Therapeutics, Buy the Dip?"
2018-06-26,"This Is the Most Undervalued NASH Drug Stock, and Wall Street Is Ignoring It"
2018-06-23,"Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives"
2018-06-18,3 Top Biotech Stocks to Buy Right Now
2018-06-15,Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers
2018-06-15,MARKETS: Here's why stocks are dropping right now
2018-06-14,Are These Red-Hot NASH Stocks Still a Buy?
2018-06-13,Madrigal Pharma Is Exploring Sale After Receiving Takeover Interest
2018-06-06,Madrigal Pharmaceuticals Prices Public Offering of Common Stock
